123 related articles for article (PubMed ID: 16055115)
1. Valsartan improves mitochondrial function in hearts submitted to acute ischemia.
Monteiro P; Duarte AI; Gonçalves LM; Providência LA
Eur J Pharmacol; 2005 Aug; 518(2-3):158-64. PubMed ID: 16055115
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of trimetazidine on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia.
Monteiro P; Duarte AI; Gonçalves LM; Moreno A; Providência LA
Eur J Pharmacol; 2004 Oct; 503(1-3):123-8. PubMed ID: 15496306
[TBL] [Abstract][Full Text] [Related]
3. Impact of imidapril on cardiac mitochondrial function in an ex-vivo animal model of global myocardial ischemia.
Monteiro P; Gala S; Nobre S; Carreira R; Gonçalves LM; Providência LA
Rev Port Cardiol; 2005 Jan; 24(1):53-61. PubMed ID: 15773666
[TBL] [Abstract][Full Text] [Related]
4. Early alteration of the control of mitochondrial function in myocardial ischemia.
Kay L; Saks VA; Rossi A
J Mol Cell Cardiol; 1997 Dec; 29(12):3399-411. PubMed ID: 9441845
[TBL] [Abstract][Full Text] [Related]
5. Pyruvate improves mitochondrial bioenergetics in an ex-vivo animal model of myocardial ischemia.
Monteiro P; Duarte A; Moreno A; Gonçalves L; Providência LA
Rev Port Cardiol; 2003 Jan; 22(1):79-88. PubMed ID: 12712812
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of cardioprotection against ischemia/reperfusion injury by valsartan: an experiment with isolated rat hearts].
Zhang YJ; Bai XJ; Qi ZM; Wang HX
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3350-3. PubMed ID: 16409843
[TBL] [Abstract][Full Text] [Related]
7. Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation.
Thai H; Guarraia D; Johnson N; Goldman S; Gaballa MA
J Cardiovasc Pharmacol; 2007 Dec; 50(6):703-7. PubMed ID: 18091589
[TBL] [Abstract][Full Text] [Related]
8. Differential changes in respiratory capacity and ischemia tolerance of isolated mitochondria from atrophied and hypertrophied hearts.
Bugger H; Chemnitius JM; Doenst T
Metabolism; 2006 Aug; 55(8):1097-106. PubMed ID: 16839847
[TBL] [Abstract][Full Text] [Related]
9. Impact of acute ischemia-reperfusion on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia.
Paiva MA; Carreira R; Monteiro P; Gonçalves LM; Providência LA
Rev Port Cardiol; 2005 Nov; 24(11):1381-92. PubMed ID: 16463987
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
[TBL] [Abstract][Full Text] [Related]
11. Simulation of cardiac work transitions, in vitro: effects of simultaneous Ca2+ and ATPase additions on isolated porcine heart mitochondria.
Territo PR; French SA; Balaban RS
Cell Calcium; 2001 Jul; 30(1):19-27. PubMed ID: 11396984
[TBL] [Abstract][Full Text] [Related]
12. Effects of valsartan on neuroprotection and neurogenesis after ischemia.
Wakai T; Yoshioka H; Yagi T; Kato T; Kinouchi H
Neuroreport; 2011 Jun; 22(8):385-90. PubMed ID: 21494160
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin-converting enzyme inhibitor versus valsartan on cellular signaling events in heart transplant.
White M; Ross H; Levesque S; Whittom L; Pelletier GB; Racine N; Meloche S; Voisin L
Ann Pharmacother; 2009 May; 43(5):831-9. PubMed ID: 19417110
[TBL] [Abstract][Full Text] [Related]
14. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
[TBL] [Abstract][Full Text] [Related]
17. Selective angiotensin receptor antagonism with valsartan decreases arterial stiffness independently of blood pressure lowering in hypertensive patients.
Nakamura T; Fujii S; Hoshino J; Saito Y; Mizuno H; Saito Y; Kurabayashi M
Hypertens Res; 2005 Dec; 28(12):937-43. PubMed ID: 16671331
[TBL] [Abstract][Full Text] [Related]
18. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
[TBL] [Abstract][Full Text] [Related]
19. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
[TBL] [Abstract][Full Text] [Related]
20. Dichloroacetate improves cardiac efficiency after ischemia independent of changes in mitochondrial proton leak.
Taniguchi M; Wilson C; Hunter CA; Pehowich DJ; Clanachan AS; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1762-9. PubMed ID: 11247790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
